Cor Therapeutics Inc. (CORR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (412)	4/26/1999 10:26:00 AM
From: LLCF	Read Replies (1) of 712

Here's the Robby Stevens upgrade: biz.yahoo.com The expect CORR to break even next year... so take in what 50mill from Integrelin?? Hhmmmm I will say this; there's always talk of the first quarter of sales being stocking orders, and so they beat that pretty good. I've also heard that this drug will compete very well with it's competition which should bode well considering the large market for this type of drug. <What am I missing? What are the sales earnings expectations of others?> Well based on their current pace... if you double sales again in 2000 you get 100 million drug, still not a huge part of the market! According to MTSL this drug is easier to use in emergency rooms because of the wider indications than the competition. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next